Since noninvasive central blood pressure (BP) measuring devices are readily available, central BP has gained growing attention regarding its clinical application in the management of hypertension. The disagreement between central and peripheral BP has long been recognized. Some previous studies showed that noninvasive central BP may be better than the conventional brachial BP in association with target organ damages and long-term cardiovascular outcomes. Recent studies further suggest that the central BP strategy for confirming a diagnosis of hypertension may be more cost-effective than the conventional strategy, and guidance of hypertension management with central BP may result in less use of medications to achieve BP control.
| INTRODUC TI ON
To maintain the circulation of blood flow, the ejection of the stroke volume into the central aorta requires the pressure generated by left ventricle to overcome the pulsatile and resistive loads of the entire arterial tree. 1 As the pressure wave (PW) propagating along the arterial bed, it increases in the whole amplitude of the pulse pressure (PP) as it travels distally, that is, a "gradual widening" of the PP between two sites of the arterial bed. The increased amplitude of arterial pulse along the elastic and conduit arteries is quantified as the blood pressure (BP) amplification; that is, systolic BP (SBP) and PP are higher at peripheral arteries than that in the central aorta. Mean BP and diastolic BP remain almost unchanged (or slightly decreases because of viscous dissipation) between the two sites. 2 Although brachial BP has been routinely measured in daily practice, many studies have been conducted to address the prognostic and therapeutic impact of this noticeable discrepancy between brachial BP and central BP. Central BP, the pressure measured from the central aorta or common carotid arteries, 1 is determined by the interaction between function of left ventricle, large arteries and arterioles, and structure of aortic root, arterial bifurcations and arterial narrowing, and may therefore directly and better reflect the impact of pulsatile load. 3 Central BP has gained growing attention concerning its clinical application in the management of hypertension since noninvasive central BP measuring devices are readily available. After the introduction of cuff-based techniques developed to obtain noninvasive central BP, [4] [5] [6] its convenient measurement can realize the use of central BP concept in daily clinical practice. Moreover, the Artery Society task force, in response to the burgeoning noninvasive central BP monitoring devices, has proposed a validation standard. 7 One of the major suggestions in the consensus statement is the further classification of central BP monitoring devices based on its purpose. It suggests to classify the devices into two types: Type I devices estimate central BP relative to the measured brachial BP, and type II devices estimate the intra-arterial central BP. 7 The features are a relatively accurate pressure difference between central and peripheral sites for type I devices and a relatively accurate absolute central BP value for type II devices.
BP measurements are conventionally obtained at the brachial arteries. Although brachial BP readings highly correlate with central BP and are the gold standard for the diagnosis and management of hypertension, substantial individual discrepancies between central and peripheral BP exist. Such discrepancies have long been a popular research topic, and whether central BP is a better clinical indicator than brachial BP has also been debated vehemently. 8, 9 In this review, we will address briefly the rationale supporting the clinical use of central BP monitoring. 10 
| ME THODS AND DE VI CE S US ED FOR NONINVA S IVE E S TIMATION OF CENTR AL BP
Pressure waveform of carotid artery is a good surrogate for central aortic pressure waveform. [11] [12] [13] However, the commonly used methodology utilizes waveforms obtained from peripheral arteries for noninvasive central BP estimation with either tonometry-based 11, [14] [15] [16] or cuff-based techniques. [4] [5] [6] The common working principles of these central BP estimations include transfer function, pulse waveform analysis, and N-point moving average (NPMA). Transfer function is a mathematical relationship between two physical properties. The details of the measurement concept and procedures can be found in research performed with a commercial apparatus. 17, 18 It has been the most popular central BP measurement device to date. Pulse waveform analysis can be used to identify waveform characteristics.
It has been shown that peak of SBP2, the late systolic should of a pressure waveform resulting from distal PW reflections agrees well with the peak of central aortic pressure waveforms (central SBP). 19, 20 Besides, using comprehensive waveform analysis including SBP2 and corresponding regression equations, central SBP and PP can be accurately estimated. 4, 21 Recently, it has been demonstrated that one can use NPMA method to estimate central aortic SBP (SBP-C). 16 NPMA is a mathematical low-pass filter that is frequently used in the engineering field for removing random noise from a time series by using a common denominator related to the sampling frequency. The high-frequency components, which cause substantial transformations from central to peripheral aortic pressure waveforms resulting primarily from arterial wave reflections, 22 can be eliminated by the application of the NPMA. 16, 23 Table 1 summarizes current available devices for measuring central BP.
It is suggested that the accuracy of central BP should be examined against the invasive measurements counterparts. 7 Accuracy of current central BP methods and devices has been investigated in several systematic review. [24] [25] [26] It seems that the accuracy is device specific, 27 and the major limitation is the accuracy of cuff BP used for waveform calibration. 24,28
| UTILIT Y OF CENTR AL B P MONITORING IN CLINI C AL PR AC TI CE

| Peripherally obtained BP does not accurately reflect central pressure because of pressure amplification
As shown in a previous study, a large proportion of subjects with high-normal brachial SBP had comparable central SBP as those with stage 1 hypertension. 29 This discrepancy was also noted for subjects with normal brachial BP, many of whose central BPs were in the same category as those with stage 1 hypertension. If central BP is a better target for therapy, the misclassification by brachial BP may lead to over-or under-treatment of hypertension and may be clinically relevant. 30 The diagnosis of hypertension, according to either office, home, or ambulatory BP measurements, is currently based on recordings from the brachial arteries. Because of the phenomenon of PP amplification, brachial SBP and PP are usually higher than the corresponding readings in the central aorta. 2, 15, [31] [32] [33] However, either by the auscultatory method or automatic oscillometric sphygmomanometers, the noninvasively measured brachial SBP and PP, are usually lower than the invasively measured intra-arterial readings. 34 As a consequence, noninvasive brachial SBP readings may approach to values of central SBP 35 ; therefore, it might be reasonable to use noninvasive brachial SBP as an estimate of central SBP.
Nonetheless, robust evidence suggests that there are substantial disagreements of central BP among individuals with similar brachial BP. 36, 37 Moreover, although the averaged invasive central SBP is similar to averaged brachial cuff SBP, there is substantial variability, that is, under and over estimation of central SBP by the cuff SBP, which refutes brachial cuff SBP being an accurate representation of central SBP. 26, 37, 38 The PP amplification, the disagreement between central and peripheral BP varies within-and between-individuals. 39 More importantly, such variability depends on a number of factors, including age, sex, body height, heart rate, medications, and systemic vascular diseases. 36, 40, 41 Besides, noninvasive brachial SBP as a surrogate for central SBP has been shown to have a large random error. 37
| Central aortic pressure is a better predictor of cardiovascular outcome than peripheral pressure
Central BP may reflect the pulsatile load on the heart and large arteries better than brachial BP, particularly in individuals with a prominent PP amplification. 3 It has been demonstrated that central SBP was more closely associated with left ventricular mass index, carotid intima-media thickness, and pulse wave velocity, compared with brachial SBP, 42, 43 whereas brachial SBP might be superior to central SBP in identifying albuminuria in patients with type 2 diabetes. 44 In addition, longitudinal studies further support that the changes of central BP rather than brachial BP related to the regression of left ventricular mass index and carotid intima-media thickness, 45, 46 and microalbuminuria and cognitive aging. 43, 47 In a systematic review of 85 studies, central compared with brachial BP seems to be more strongly associated with most of the investigated indices of preclinical organ damage. 42 With regard to the relationship between central BP and cardiovascular outcomes, we previously showed that central SBP and PP were more predictive of cardiovascular mortality than brachial SBP and PP in a Taiwanese cohort. 48 In addition, central SBP and PP were significantly associated with cardiovascular events, as well as brachial measurements, in a meta-analysis of 11 studies with 5648 subjects, 49 Table 2 . Recently, the clinical benefits of different antihypertensive agents observed in the ASCOT study were more associated with the reduction of central rather than brachial BP, 17 which ignited the application of central BP for clinical practice. 50 If precision of central BP measurement could be improved, as for some type II central BP devices, we may see more substantial prognostic difference.
| Antihypertensive medications have differential effects on central pressures despite similar reductions in brachial BP
It has long been recognized that individual discrepancies between central and peripheral BP may be magnified during hemodynamic changes or after pharmacological interventions. 24 The differential responses of central BP vs brachial BP to various antihypertensive agents are highly variable among individuals in clinical studies. 51, 52 It has been suggested that angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and dihydropyridine calcium channel blockers, as well as nitrates, may have a more beneficial effect on central BP than beta-blockers, despite their similar effects on brachial BP. 53, 54 Randomized controlled trials investigating the differential response between central and peripheral BP to different classes of pharmacological interventions have been summarized in Table 3 .
Similarly, various classes of antihypertensive drugs may exert different effects on the PP amplification. Compared with diuretics and beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, dihydropyridine calcium blockers, and nitrates may exert a favorable effect on the PP amplification. 3, 30, 55, 56 The observed less beneficial effect of beta-blockers (mainly atenolol) on cardiovascular outcomes 57 could be explained by the unfavorable effect on the PP amplification. 17, 53 These speculations were supported by the CAFE substudy of the ASCOT trial, 17 
| Isolated central hypertension and isolated brachial hypertension are associated with increased cardiovascular risks
The discrepancy between central and brachial BP could be used to define phenotypes of hypertension. (Figure 1 ). 62 Subjects with isolated central hypertension had a significantly higher estimated 10-year coronary heart disease risk than those without central or brachial hypertension. 62 In the Northern Shanghai study, elderly Chinese subjects with isolated central hypertension had higher levels of left ventricular mass index, carotid-formal pulse wave velocity, and urinary albumin-creatinine ratio than those without central or brachial hypertension. 63 Moreover, based on the 2017 ACC/AHA hypertension threshold, a higher proportion of subjects with isolated brachial hypertension thresholds (130/80 mm Hg) has been identified ( Figure 1 ). 64 Subjects with isolated brachial hypertension had an increased risk of coronary heart disease similar to those with isolated central hypertension and were characterized by young age, male sex, and a high prevalence of isolated diastolic hypertension, implying minimal evidence of the presence of arterial stiffness or vascular aging. 64 
| FUTURE PER S PEC TIVE S ON THE US E OF CENTR AL B P TO MANAG E HYPERTENS ION
We have evidently shown in a previous systematic review that current central BP estimating methods are theoretically suitable. 24 However, the major errors of these central BP measurement techniques result from the inaccurate noninvasive BP used to calibrate the peripheral waveforms. In a recently published systematic review, cuff BP has variable accuracy for measuring either brachial or aortic intra-arterial BP, which adversely influences correct BP classification 26 and inevitably makes waveform calibration inadequate. Therefore, the measurement accuracy of both noninvasive brachial and central BP still has room for improvement. 26, 65 Recently, World Hypertension League, International Society of Hypertension, and other supporting hypertension organizations have together issued a position statement to call for regulating manufacture and marketing of BP devices and cuffs. 66 With the joint efforts, validated automatic BP devices are more readily available and more accurate noninvasive brachial and central BP measurements could be rendered in the care of cardiovascular patients.
Despite that central BP may be better than brachial BP in predicting cardiovascular outcomes, 5, 20, 22 it is arguable that the in- 
| CON CLUS IONS
In this brief review, we summarized the rationale supporting the clinical utility of central BP since it can be conveniently measured noninvasively. Noninvasive central BP is likely better than the conventional brachial BP in association with target organ damages and long-term cardiovascular outcomes, but more evidence is required to support the use of central BP in diagnosing hypertension and monitoring the management of hypertension with central BP in routine clinical practice. 
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